| Subscribe To Our Free Newsletter |
Bino Pathiparampil expects positive momentum in pharma sector; has 3 top picks
Bino Pathiparampil of Elara Capital discussed the strong Q1 FY25 performance in the pharma sector. Companies like Lupin and Dr Reddy's received upgrades, largely due to their success in the US market. Despite high valuations, the sector's positive momentum is likely to persist, with Zydus Lifesciences noted for future product launches.
